Clinical Trials in Phoenix, Arizona

Find clinical trials in Phoenix, Arizona. Discover local research opportunities and treatment options in your area.

970 Active Trials Found in Phoenix

Showing 970 trials on this page

Page 1 of 49

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

NCT ID: NCT00342927

The Family Investigation of Nephropathy and Diabetes (F.I.N.D.) is a research study aimed at understanding the genetic factors that contribute to diabetic kidney disease. This study will take place...

Recruiting

Conditions: Diabetes Mellitus, Diabetic Nephropathy +2 more

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT ID: NCT04267848

The ALCHEMIST trial is a clinical study looking at whether adding a drug called pembrolizumab, which is a type of immunotherapy, to standard chemotherapy can improve treatment outcomes for patients...

Recruiting

Phase: PHASE3 Conditions: Stage IIIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 +4 more

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

NCT ID: NCT04269902

**Summary of the EVOLVE CLL/SLL Study** The EVOLVE CLL/SLL study is a clinical trial designed to find out if starting treatment for high-risk chronic lymphocytic leukemia (CLL) or small lymphocyti...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

NCT ID: NCT04929041

This clinical trial is studying whether adding radiation therapy to the usual treatment for stage IV non-small cell lung cancer (NSCLC) can improve outcomes for patients whose tumors are negative f...

Recruiting

Phase: PHASE2 Conditions: Stage IV Lung Cancer AJCC v8, Lung Adenocarcinoma +4 more

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

NCT ID: NCT05058651

This clinical trial is studying the effects of a new immunotherapy drug called atezolizumab when combined with standard chemotherapy for patients with advanced or metastatic neuroendocrine carcinom...

Recruiting

Phase: PHASE2 Conditions: Recurrent Extrapulmonary Neuroendocrine Carcinoma, Unresectable Extrapulmonary Neuroendocrine Carcinoma +2 more

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

NCT ID: NCT05323253

This clinical trial is studying a new treatment called Alpha DaRT224 for patients with recurrent skin cancer known as cutaneous squamous cell carcinoma (SCC). The goal is to see how effective and s...

Recruiting

Phase: NA Conditions: Recurrent Squamous Cell Carcinoma

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT ID: NCT05554406

This clinical trial, called the MyeloMATCH Treatment Trial, is investigating different treatment options for adults who have recently been diagnosed with a serious form of blood cancer called high-...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm +2 more

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT ID: NCT05564390

The MYELOMATCH trial is a research study designed to help people with certain types of blood cancers, specifically acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The main goal of ...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

NCT ID: NCT05675410

This clinical trial is studying whether adding two specific drugs, brentuximab vedotin and nivolumab, to the standard treatment for early-stage Hodgkin lymphoma can help patients live longer and ex...

Recruiting

Phase: PHASE3 Conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05882877

This clinical trial is studying a medication called rocatinlimab to see how safe it is and how well it works for people aged 12 and older who have moderate to severe atopic dermatitis, which is a t...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

Strategy for Improving Stroke Treatment Response

NCT ID: NCT05948566

The SISTER trial is a research study looking at a new treatment for acute ischemic stroke, which happens when a blood clot blocks blood flow to the brain. This study is testing a medication called ...

Recruiting

Phase: PHASE2 Conditions: Ischemic Stroke

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT ID: NCT05987241

The MODERN study is a clinical trial designed to explore how a blood test can help identify bladder cancer patients who may need additional treatment after having their bladder surgically removed. ...

Recruiting

Phase: PHASE2 Conditions: Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7 +5 more

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

NCT ID: NCT06090539

This clinical trial is testing a new medication called BMS-986458 to see how safe it is and how well it works for patients with relapsed or refractory non-Hodgkin lymphoma (NHL). This means the stu...

Recruiting

Phase: PHASE1 Conditions: Relapsed/Refractory Non-Hodgkin Lymphoma

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT ID: NCT06172296

This clinical trial is studying a new treatment approach for children with high-risk neuroblastoma, a type of cancer that affects nerve cells. The researchers want to find out if combining a medici...

Recruiting

Phase: PHASE3 Conditions: Neuroblastoma, Ganglioneuroblastoma, Nodular

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

NCT ID: NCT06312020

This clinical trial is investigating a new treatment called HZN-1116 for people with Sjogren's syndrome, a condition that affects moisture-producing glands and can cause dry mouth and eyes, among o...

Recruiting

Phase: PHASE2 Conditions: Sjogren's Syndrome

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT ID: NCT06422806

This clinical trial is studying whether adding a type of treatment called immunotherapy (specifically pembrolizumab) to standard chemotherapy (doxorubicin) can help patients with aggressive types o...

Recruiting

Phase: PHASE3 Conditions: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Metastatic Undifferentiated Pleomorphic Sarcoma +4 more

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

NCT ID: NCT06664619

This clinical trial is testing a new inhaler that combines two medications, fluticasone propionate and albuterol sulfate, to see how well it works and how safe it is for people aged 12 and older wi...

Recruiting

Phase: PHASE3 Conditions: Asthma

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

NCT ID: NCT06690294

This clinical trial is looking at how experiences from childhood can affect how adults eat and manage their weight. Researchers want to understand if certain life events during childhood influence ...

Not yet recruiting

Conditions: Healthy Volunteer, Obestity

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858839

This clinical trial is studying a medication called maridebart cafraglutide to see if it can help adults who are overweight or obese lose more weight compared to a placebo, which is an inactive tre...

Recruiting

Phase: PHASE3 Conditions: Obesity

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858878

This clinical trial is exploring a new medication called maridebart cafraglutide to see how effective it is for adults with type 2 diabetes who are also overweight or have obesity. The main goal is...

Recruiting

Phase: PHASE3 Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight